Printer Friendly

ID Biomedical Corporation - Incentive Options Granted.

VANCOUVER, BRITISH COLUMBIA--(BUSINESS WIRE)--Nov. 22, 1996--ID BIOMEDICAL CORPOR (TSE IDB.,NASDAQ IDBEF.) ID Biomedical Corporation (IDB) announced today that it has granted incentive stock options to purchase up to 132,500 common shares to a Director of the Company, a Director of a subsidiary and three Service Providers of the Company, pursuant to IDB's Stock Option Plan. The stock options are exercisable on or before November 22, 1999, at a price of Cdn$4.85 per common share. The exercise price of Cdn$4.85 is based on the closing price per share of the Company's common shares on The Toronto Stock Exchange on November 21, 1996.

ID Biomedical is a North American biotechnology company which is developing a DNA diagnostic system and related products based on its proprietary CPT technology. The Company, through its subsidiary ID Vaccine Corporation, is also engaged in the development of subunit vaccines and immunotherapeutics against infectious diseases.


CONTACT: ID Biomedical Corporation

Hugh Notman, 604/431-9314

COPYRIGHT 1996 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 22, 1996
Previous Article:IPC announces the departure of Gregory Riedel, chief financial officer.
Next Article:Vescan Equities Further Acquisitions in the Fortune Minerals (Form-Z) Nico Discovery Area.

Related Articles
Option options.
Using stock-based compensation plans.
How does your pay stack up?
Incentive stock options revisited.
Advice for companies planning to issue stock options.
Stock Options.
Consider all options for options.
How to boost pay for performance: companies could build better incentives in their executive compensation plans by adopting pay policies that tie...
Get better results from long-term incentive pay: performance-based long-term incentives do not merely reduce the variance in earnings or reduce P & L...

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters